AlloVir chief medical officer to leave the company

S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

AlloVir chief medical officer to leave the company

To read the full story on Seeking Alpha, click here.

AlloVir (NASDAQ:ALVR)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more AlloVir Charts.

AlloVir (NASDAQ:ALVR)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more AlloVir Charts.

AlloVir Inc News

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 7 May 2024 (5 hours ago) • Edgar (US Regulatory)

Class Action Filed Against AlloVir, Inc. (ALVR) Seeking Recovery for Investors - Contact The Gross Law Firm
Thursday 14 March 2024 (2 months ago) • PR Newswire (US)

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of March 19, 2024 in AlloVir, Inc. Lawsuit - ALVR
Thursday 7 March 2024 (2 months ago) • PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 22 February 2024 (2 months ago) • Edgar (US Regulatory)

Class Action Filed Against AlloVir, Inc. (ALVR) Seeking Recovery for Investors - Contact The Gross Law Firm
Thursday 22 February 2024 (2 months ago) • PR Newswire (US)

Form 144 - Report of proposed sale of securities
Wednesday 21 February 2024 (2 months ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Tuesday 20 February 2024 (3 months ago) • Edgar (US Regulatory)

Form RW - Registration Withdrawal Request
Thursday 15 February 2024 (3 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Monday 12 February 2024 (3 months ago) • Edgar (US Regulatory)

Shareholders that lost money on AlloVir, Inc.(ALVR) Urged to Join Class Action - Contact The Gross Law Firm to Learn More
Friday 9 February 2024 (3 months ago) • PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 6 February 2024 (3 months ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Monday 5 February 2024 (3 months ago) • Edgar (US Regulatory)

More AlloVir Inc News Articles

Moon Equity (PK)

Globestar Therapeutics (PK)

Greene Concepts (PK)

MicroCloud Hologram

Therapeutic Solutions (PK)

Clean Vision (QB)

FuelCell Energy

Progressive Care (QB)

TPT Global Tech (CE)

Digital Brand Media and ... (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions